Fig. 4
From: B7-H3 and ICAM-1 are potentially therapeutic targets for thyroid carcinoma
Expression levels of B7-H3 and ICAM-1 protein in thyroid carcinoma in our cohort. A. Immunohistochemical expression of B7-H3 in thyroid carcinomas (n = 28) and paired adjacent normal tissue (n = 28) (left). Immunohistochemical expression of B7-H3 in each thyroid carcinoma sample(right). B. Immunohistochemical expression of ICAM-1 in thyroid carcinomas (n = 28) and paired adjacent normal tissue (n = 28) (left). Immunohistochemical expression of ICAM-1 in each thyroid carcinoma sample(right). C. The correlation between the clinical features of PTCs (patient's age and gender) and B7-H3 (CD276) or ICAM-1 (CD54) protein expression